Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit ...

It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...

A treatment used a gene-editing tool to turn off a gene that prevents LDL cholesterol and triglycerides from being cleared ...

Bristol Myers Squibb is adding three prescription medications on TrumpRx.gov on Monday, offering discounts of up to 90%, FOX ...

U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices ...

The platform now features a total of 54 discounted prescription medications available from six participating companies.

Merck's experimental cholesterol buster easily outperformed a triplet of medications, the Dow Jones component said Monday.

Merck & Co.’s experimental cholesterol pill slashed levels of the artery-clogging plaque far more than older tablets in the ...

MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha(R) (evolocumab injection) for eligible ...

In late March 2026, the FDA warned of severe liver injuries, including vanishing bile duct syndrome, linked to ...